>>  NEWS


LBD Life Sciences (China) Ltd.:
ADD:Floor 4 Building 21, NO.88 Darwin Road Zhangjiang Hi-Tech Park District, Pudong District Shanghai, China
FAX: 02151821822
新闻资讯 HOME > 新闻资讯


SPT Life Sciences Acquires LBD Life Sciences
You are theperson to read this article  Release time:2020-9-15 21:04:03

Shanghai, China, 15 September 2020: LBD Life Sciences is pleased to announce that LBD has been embedded into SPT Life Sciences aggressive growth plans, and became a wholly-owned subsidiary of SPT Life Sciences.

For over 10 years, LBD Life Sciences has successfully developed Chinese life science market with its reputation and popularity gradually increased. With close collaboration and continuous support from SPT Labtech, the team has gained customer recognition with dedicated and professional services. We have brought world-leading application knowledge and engineering capabilities to Chinese life science research community to accelerate their researches.

SPT Labtech, the global leader in liquid handling and sample management, has designed and built a portfolio of high end solutions that help improve efficiency, increase agility, support miniaturization and streamline life science research. The company's products streamline critical workflows and increase agility, efficiency and productivity across drug discovery, structural biology, genomics, Cryo-EM, sample management and biobanking.

Patrick Bennett, Group CEO of SPT Life Sciences, said, "We are delighted to complete the deal and we are very excited to bring LBD into the group. This investment highlights SPT Life Sciences commitment to developing a global portfolio of companies with a range of specialties that help life science professionals world-wide to achieve their research goals. For over 10 years, the team at LBD have supported the growing life science research community in China and we believe that this investment will ensure they are able to do so going forward.”

Ying Yang, previously chairwoman of LBD Life Science said, “we have witnessed an increasing attention and capital flow into Chinese life science in recent years. With the dramatic increase in needs for improving workflows in drug discovery, structural biology, sample management, biobanking and genomics applications, we believe this integration would further benefit Asia’s research and development community.”

Sean Xiao, managing director of LBD Life Science commented “as part of SPT Life Sciences, we will remain deeply committed to solving Asia’s life science customers' toughest research problems by leveraging our global expertise, and enabling access to cutting edge instrumentation. We can see many advantages of being part of the global platform and look forward to our bright future.”

About SPT Life Sciences

SPT Life Sciences is a global group of innovative technology companies, focused on enabling the life sciences industry to deliver more effective research. Its aim is to provide customers with leading edge solutions to enhance the quality, speed, and cost of their experimentation or analytical workflows.

About LBD Life Sciences

LBD was founded in Shanghai. It is focused on serving biotech and pharmaceutical companies as well as research institutions in China, introducing cutting edge technologies and world leading products to help accelerate research and make a difference in science. LBD’s vision is to be the most reliable technical advisor for scientists in life science research.

Learn more about SPT: https://www.sptlifesciences.com/

Or email to: marketing@lbd-life.com


Print this page】 【 Close page

CopyRight 2012 LBD Life Sciences China Limited.
Add:Floor 4 Building 21, NO.88 Darwin Road Zhangjiang Hi-Tech Park District, Pudong District Shanghai, China 201203
Tel:086-21-51088608 Fax:086-21-51821822